Venous thromboembolism (VTE) is common in patients with cancer and increases morbidity and mortality. VTE prevention and treatment are more complex in patients with cancer. The NCCN Guidelines for Cancer-Associated Venous Thromboembolic Disease outline strategies for treatment and prevention of VTE in adult patients diagnosed with cancer or in whom cancer is clinically suspected. These NCCN Guidelines Insights explain recent changes in anticoagulants recommended for the treatment of cancer-associated VTE.
|Original language||English (US)|
|Number of pages||15|
|Journal||JNCCN Journal of the National Comprehensive Cancer Network|
|State||Published - Nov 1 2018|
ASJC Scopus subject areas